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Accelerated fibrosis and collagen deposition develop in the renal
interstitium of angiotensin type 2 receptor null mutant mice during
ureteral obstruction. We examined the role of angiotensin in renal
remodeling that is specifically channeled through the angiotensin type 2
receptor (AT2 receptor). Previously, we observed that in mouse embryonic
kidneys the AT2 mRNA is predominantly expressed in the mesenchyme.
We therefore chose a model of unilateral ureteral obstruction, character-
ized by activation of the renin-angiotensin system, while fibrosis develops
prominently within the renal interstitium. Male wild-type mice (Agtr2
2/Y) and mice null mutant for the AT2 gene (Agtr2 2/Y) were subjected
to a complete unilateral ureteral ligation for 5 or 14 days. Obstructed
kidneys of Agtr2 2/Y mice showed more severe interstitial fibrosis than
those of Agtr2 1/Y mice, confirmed by increased collagen by point-
counting on Masson trichrome stained sections, and increased a1(I)
collagen mRNA expression by Northern blot. Immunohistochemistry
staining for PCNA (a marker of cell proliferation), F4/80 (a marker of
macrophages), vimentin (a marker of fibroblasts), and aSMA (a marker of
myofibroblasts) revealed that, while the two groups were comparable in
the degree of cell proliferation and macrophage infiltration, fibroblasts/
myofibroblasts were present in a greater abundance in obstructed kidneys
of Agtr2 2/Y mice than in Agtr2 1/Y at both 5 and 14 days after
obstruction. Moreover, cells undergoing apoptosis were significantly less
in Agtr2 2/Y than in Agtr2 1/Y. Thus, the AT2 receptor significantly
impacts the remodeling process within renal interstitium, potentially by
regulating the population of collagen-producing cells.
While most of the known effects of angiotensin II (Ang II) are
mediated by its type 1 receptor (AT1) [1], the function of type 2
receptor (AT2) has not been fully elucidated. Some investigators
suggest that AT2 is involved in control of cell proliferation and
differentiation [2, 3]. Several recent studies indicate that AT2 is
involved in apoptosis [4, 5]. Although AT2 expression is down-
regulated after birth, it is speculated that AT2 plays a role in tissue
remodeling or repair of vascular and cutaneous tissues under
some pathophysiological conditions [6–9].
It has been widely accepted that, in a variety of renal diseases,
the degree of tubulointerstitial changes observed in the early stage
of a disease predicts the long-term outcome of renal function [10,
11]. Since experimental unilateral ureteral obstruction (UUO)
activates the renal renin-angiotensin system (RAS) [12, 13], and
since AT2 is predominantly expressed in the renal interstitium, at
least in embryos [14], it appeared conceivable that RAS, via AT2,
modulates the intense and persistent tubulointerstitial changes
that follow UUO [15–18]. To assess this role of RAS, we studied
mice with UUO whose AT2 was selectively deleted by gene
targeting [19].
METHODS
Animals
Male wild-type and angiotensin II type 2 receptor gene (Agtr2)
null mutant mice (Agtr2 1/Y and Agtr2 2/Y, respectively) were
used in this study. These animals were the offspring of the Agtr2
deletion mutants generated earlier in our laboratory by gene
targeting [19]. (Animals used are the offspring of a pair that
produced no Agtr2 2/Y or Agtr2 2/2 mice with anomalies in the
kidney or urinary tract system [20].) The genotypes of these mice
were screened by Southern blot analysis of tail DNA as previously
described [19].
Left ureters of mice at 10 to 12 weeks of age were double
ligated with 6-0 silk and cut between the two ligated points. The
upper ligation was consistently placed exactly at the level of the
lower pole of the kidney. At 5 or 14 days after surgery, both
obstructed and contralateral kidneys were harvested (day 5: N 5
7 for Agtr2 1/Y and N 5 8 for Agtr2 2/Y, day 14: N 5 6 for Agtr2
1/Y and N 5 7 for Agtr2 2/Y).
Detection of renal AT2 mRNA expression
One microgram of total RNA was reverse transcribed by AMV
reverse transcriptase with Oligo dT15 primer (Promega, Madison,
WI, USA). Polymerase chain reaction (PCR) was performed to
determine the AT2 mRNA expression in both kidneys [21]. The
amplification condition was 40 cycles at 94°C for one minute, 58°C
for one minute, and 72°C for three minutes. Expression of
GAPDH mRNA in same kidney served as a positive control of
reverse transcription-polymerase chain reaction (RT-PCR).
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Histological study
Kidneys were cut into transverse sections 2 mm thick, fixed with
4% buffered paraformaldehyde overnight, embedded in paraffin,
and sectioned into 3 mm thickness, and subjected to histological
examinations.
(1.) Morphometric analysis of interstitial collagen in the renal
cortex. A standard point-counting method was employed to quan-
titate the collagen fractional volume of renal cortical interstitium
on Masson trichrome stained sections [22]. Under high magnifi-
cation of 403 objective, 20 consecutive non-overlapping fields,
that is, a total of 1,899 to 1,972 points of renal cortex in each
kidney were observed. Trichrome stain positive points falling on
glomeruli, Bowman’s capsules or vessels were excluded, while
interstitial trichrome-positive points were counted for evaluation
[22]. The index of interstitial collagen volume was defined as the
number of trichrome-positive points in every 2000 points evalu-
ated.
(2.) Morphometric analysis of macrophage infiltration, proliferat-
ing cells and fibroblasts in the renal cortex. Antigen retrieval
treatment with 0.1% trypsin/Tris (pH 7.6) was applied for immu-
nohistochemical studies. Macrophage infiltration was detected by
the ABC method (Vectastain® ABC kit; Vector Laboratories,
Burlingame, CA, USA) by rat antimouse F4/80 antigen (Serotec,
UK) [23]. EPOS-anti-vimentin, EPOS-anti-a-smooth muscle actin
(aSMA) and EPOS-anti-proliferating cell nucleic antigen
(PCNA) (DAKO, Denmark) conjugated with HRP were used to
identify the fibroblasts, myofibroblasts and proliferating cells.
Adjacent sections were subjected to vimentin and aSMA staining.
For each kidney, 10 randomly selected cortical fields were exam-
ined under high magnification of 1003 objective for evaluation of
macrophages and fibroblasts, and under high magnification of
403 objective to evaluate proliferating cells. The positively
stained cells located in the tubulointerstitial area only were
counted and the numbers were averaged for each field.
Detection of a1(I) collagen mRNA expression in five-day
obstructed kidneys
Fifteen micrograms of total RNA extracted from kidney ho-
mogenates was used for Northern blot analysis probed with rat
a1(I) cDNA [24] and human GAPDH cDNA (Clontech, Palo
Alto, CA, USA), the latter used as a control for RNA loading.
The band of each specific mRNA was identified, and semiquan-
titated by an image analyzer (Molecular Dynamics, Sunnyvale,
CA, USA). The density of the bands for a1(I) collagen was
normalized by that for GAPDH.
Study of apoptosis
In situ end-labeling (TUNEL method) was performed to detect
the apoptotic cells in tubulointerstitial tissue [25]. For each
kidney, apoptotic cells in 10 consecutive non-overlapping fields of
renal cortex were counted under high magnification of 403
objective. The number of positive nuclei was averaged for each
field [26].
Statistical analysis
Data are presented as mean 6 SEM. Statistical significance was
evaluated by analysis of variance (ANOVA), and set at P , 0.05.
RESULTS
mRNA expression of AT2 in kidneys
RT-PCR assessment showed that AT2 mRNA expression was
detectable in both obstructed and contralateral kidneys in Agtr2
1/Y animals, while no expression was found in Agtr2 2/Y mice
(Fig. 1).
Morphological changes in obstructed kidneys
Tubular dilation, tubular basement thickening and tubular
atrophy were present in both 5-day and 14-day obstructed kidneys
from both Agtr2 1/Y and Agtr2 2/Y mice (Fig. 2). Qualitatively,
the obstructed kidneys of Agtr2 2/Y mice had more severe cortical
interstitial changes compared to those of Agtr2 1/Y mice, includ-
ing widening of interstitial space, increase in cellularity and loss of
close contact between peritubular capillaries and tubules with
increased intervening trichrome stain-positive materials (Figs. 2
and 3). Indices of interstitial collagen averaged 38.1 6 4.3 versus
17.4 6 2.9 (P , 0.05) and 93.8 6 11.7 versus 57.4 6 3.5 (P , 0.01)
in Agtr2 2/Y and Agtr2 1/Y mice at day 5 and day 14, respectively.
There was no significant interstitial fibrosis and no difference in
interstitial collagen between the two genotypes in the contralat-
eral unobstructed kidneys.
mRNA expression of a1(I) collagen in five-day obstructed
kidneys
Northern blot showed a greater increase in mRNA expression
for a1(I) collagen in five-day obstructed kidneys of Agtr2 2/Y
mice when compared with that of Agtr2 1/Y (0.25 6 0.02 vs.
0.41 6 0.03, P , 0.01; Fig. 4).
Immunohistochemical studies
F4/80-positive cells were present primarily in the interstitium of
the obstructed kidney, while there were only few in glomeruli. As
shown in Figure 5, in both 5- and 14-day UUO animals, there was
no appreciable difference between Agtr2 1/Y and Agtr2 2/Y mice
in ipsilateral or contralateral kidneys, and no change from day 5 to
day 14 (5-day obstructed kidney, 21.6 6 1.8 vs. 18.0 6 2.0; 14-day
obstructed kidney, 19.1 6 1.6 vs. 20.9 6 2.8; 5-day contralateral
kidney, 9.0 6 1.1 vs. 8.1 6 0.8; 14-day contralateral kidney, 8.2 6
0.7 vs. 9.0 6 1.4 cells/1003 field).
Vimentin-positive cells were found in the renal interstitium,
glomeruli, vessel walls, and capillary endothelia in both ipsilateral
and contralateral kidneys (left panels, Fig. 6). Obstructed kidneys
of Agtr2 2/Y mice had significantly more vimentin stained cells in
cortical interstitial areas than in wild-type animals at either
time-point (5-day, 23.7 6 1.5 vs. 15.0 6 2.1 cells/1003 field, P ,
0.05; 14-day, 48.3 6 2.0 vs. 30.8 6 2.1 cells/1003 field, P , 0.01).
Moreover, kidneys of 14-day UUO mice had more vimentin
stained cells in the interstitial space than those of 5-day UUO
mice (P , 0.05; Figs. 6 and 7). There were no differences in
vimentin staining in contralateral kidneys between these different
genotypes.
Cells with aSMA-positive staining were located in the renal
interstitium and vessel walls (right panels, Fig. 6). Most of these
aSMA-positive cells were also vimentin-positive as shown by
examining adjacent sections. In a manner similar to vimentin
positivity, therefore, aSMA-positive cells were more abundant in
the interstitium of obstructed kidneys from Agtr2 2/Y mice than
that from wild-type (5-day Agtr2 1/Y, 18.2 6 1.9; 5-day Agtr2 2/Y,
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25.9 6 2.3 cells/1003 field, P , 0.01; 14-day Agtr2 1/Y, 28.4 6 2.2;
14-day Agtr2 2/Y, 45.7 6 2.4 cells/1003 field, P , 0.01; Fig. 6).
PCNA-positive cells were mainly tubular epithelial cells in both
the obstructed and contralateral kidneys. In obstructed kidneys,
there were also a few PCNA-positive interstitial cells and capillary
endothelial cells. Obstruction increased PCNA-positive cells in
both groups of animals. However, there was no difference in
PCNA-staining between Agtr2 1/Y and Agtr2 2/Y at any time-
point (5-day obstructed kidney, 7.3 6 0.8 vs. 6.4 6 1.0; 14-day
obstructed kidney, 4.8 6 0.4 vs. 4.7 6 0.6; 5-day contralateral
kidney, 2.8 6 0.2 vs. 3.0 6 0.3; 14-day contralateral kidney, 2.0 6
0.1 vs. 2.2 6 0.2 cells/403 field). In both wild-type and null mutant
mice, 14-day obstructed kidneys had fewer PCNA-positive cells
than at 5 days of UUO (P , 0.05; Fig. 8).
Examination for apoptotic cells
In situ end-labeling (ISEL) revealed no appreciable difference
between the Agtr2 1/Y and Agtr2 2/Y obstructed kidneys (9.0 6
1.3 vs. 11.5 6 1.3 cells/403 field). However, the Agtr2 2/Y mice
had fewer ISEL-positive cells in the obstructed kidneys than Agtr2
1/Y mice after 14 days of UUO (9.1 6 1.8 vs. 19.7 6 3.5 cells/403
field, P , 0.01). The detected apoptotic cells were mainly
localized in tubules, with a few seen in the interstitium. In
contralateral kidneys of each group, no ISEL-positive cells was
detected (Figs. 9 and 10).
Fig. 1. Angiotensin type 2 receptor (AT2)
expression in obstructed and contralateral
kidneys. AT2 mRNA is demonstrable in
obstructed kidneys of Agtr2 1/Y mice (A-D),
whereas, in Agtr2 2/Y mice (E, F), no AT2
mRNA is detectable. (A) Contralateral and (B),
obstructed kidney of Agtr2 1/Y after 5-day
unilateral ureteral obstruction (UUO); (C)
contralateral and (D), obstructed kidney of
Agtr2 1/Y after 14-day UUO; (E) obstructed
kidney of Agtr2 2/Y after 5-day and (F), after
14-day UUO. The size of the amplicons are 1.2
kb for AT2, and 236 bp for GAPDH.
Fig. 3. Quantitative analysis of cortical tubulointerstitial collagens in
5-day and 14-day unilateral ureteral obstruction (UUO) of Agtr2 1/Y and
Agtr2 2/Y mice. Obstructed kidneys of Agtr2 2/Y mice (M) have more
collagen deposition than Agtr2 1/Y (f) after 5 days and 14 days of UUO.
Values are expressed as mean 6 SEM. *P , 0.05, **P , 0.01. Quantifi-
cation was based on Masson trichrome-stained sections by point-counting
method.
Fig. 4. Northern blot analysis of a1(I) collagen mRNA expression in
5-day obstructed kidneys of Agtr2 1/Y and Agtr2 2/Y mice. Expression of
a1(I) collagen mRNA in 5-day obstructed kidneys of Agtr2 2/Y (3, 4) mice
is increased when compared with that of Agtr2 1/Y (1, 2) mice. 1 and 2,
Agtr2 1/Y; 3 and 4, Agtr2 2/Y.
Fig. 5. Quantitative analysis of macrophage (F4/80-positive cell) infiltra-
tion in the cortical interstitium of 5-day and 14-day obstructed (f) and
contralateral (o) kidneys of Agtr2 1/Y and Agtr2 2/Y mice. Macrophage
infiltration was much greater in obstructed kidneys than contralateral
kidneys. However, there was no detectable difference between Agtr2 1/Y
and Agtr2 2/Y mice at 5- or 14-days of unilateral ureteral obstruction
(UUO). In addition, there is no further increase in macrophage infiltra-
tion in 14-day obstructed kidneys compared to 5-day obstructed kidneys.
Values are expressed as mean 6 SEM. *P , 0.05.
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Fig. 2. Morphology in 5-day and 14-day unilateral ureteral obstruction (UUO) of Agtr2 1/Y and Agtr2 2/Y mice. Tubular dilation, atrophy and
basement membrane thickening are present in obstructed kidneys (A-D). In either 5-day UUO (A, B) or 14-day UUO (C, D), the obstructed kidneys
of Agtr2 2/Y mice (B, D) are more cellular and have more extensive collagen deposition in the interstitium compared to Agtr2 1/Y mice (A, C). (A)
Agtr2 1/Y, 5-day UUO; (B) Agtr2 2/Y, 5-day UUO; (C) Agtr2 1/Y, 14-day UUO; D, Agtr2 2/Y, 14-day UUO. Black bars indicate 0.1 mm (Masson
trichrome staining).
Fig. 9. Demonstration of tubulointerstitial apoptosis in obstructed kidneys of 5-day and 14-day unilateral ureteral obstructed (UUO) mice by in situ
end-labeling. The difference in in situ end labeled (ISEL)-positive cells is obvious in the tubulointerstitia of 14-day obstructed kidneys between Agtr2
1/Y (C) and Agtr2 2/Y (D) mice, while no appreciable difference can be seen in 5-day obstructed kidneys between the two genotypes (A, B). (A) Agtr2
1/Y, 5-day UUO; (B) Agtr2 2/Y, 5-day UUO; (C) Agtr2 1/Y, 14-day UUO; (D) Agtr2 2/Y, 14-day UUO. Black bars indicate 0.1 mm (TUNEL).
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Fig. 6. Detection of fibroblasts (Vimentin-positive cells) and myofibroblasts (aSMA-positive cells) in obstructed kidneys following 5-day and 14-day
unilateral ureteral obstruction (UUO). Adjacent sections were used in this study. Left panels show the immunohistochemical staining for vimentin
representing fibroblasts, while right panels for alpha smooth muscle actin (aSMA) representing myofibroblasts. At either day 5 (A, B) or day 14 (C, D)
following UUO, there are more vimentin-positive and aSMA-positive cells in the obstructed kidneys of Agtr2 2/Y (B, D) mice when compared with
Agtr2 1/Y (A,C) mice. (A) 5-day Agtr2 1/Y; (B) 5-day Agtr2 2/Y; (C) 14-day Agtr2 1/Y; (D) 14-day Agtr2 2/Y. Black bars indicate 0.1 mm.
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DISCUSSION
While the effects of angiotensin II (Ang II), such as vasocon-
striction, aldosterone synthesis and release, are known to be
mediated by the type 1 receptor (AT1) [1], the function of type 2
receptor (AT2), has not been fully elucidated. Some investigators
suggest that AT2 is involved in the control of cell proliferation and
differentiation [2, 3]. A few recent studies indicate that AT2 may
be involved in cell apoptosis [4, 5]. Although AT2 expression is
dramatically decreased after birth [14], it is postulated that
up-regulation occurs during wound healing [6], vascular neoin-
tima formation [7] and post-myocardial infarction [8]. In addition,
it is reported that high densities of AT2 are associated with fibrous
tissue in human atrium with coronary artery disease [9]. In this
context, AT2 might be involved in tissue remodeling or repair
under some pathophysiological circumstances, although the re-
sults of in vitro studies on vasculatures, cardiac tissues, and
cultured fibroblasts are still controversial [27–32]. In the present
study, we demonstrated that AT2 expression in adult wild-type
mice is still detectable by RT-PCR method.
It has already been shown by others that five to seven days of
ureteral obstruction causes tubular atrophy, tubular basement
membrane thickening, and an increase in interstitial collagen
along with a further expansion of interstitial space, progression of
monocyte/macrophage infiltration, and proliferation of interstitial
fibroblasts. These changes became more obvious after two weeks
of obstruction [17, 18, 33, 34]. Proliferation of tubulointerstitium
in the obstructed kidney begins within one day after UUO,
reaches a peak level at days 6 to 9, and continues until day 15 [33].
It has been documented that an increase in apoptosis is accom-
panied by a loss of kidney weight at two to four weeks following
UUO [33, 35]. Based on these earlier observations by others, we
chose day 5 and day 14 as our time-points for examining the renal
histology in UUO mice.
In our present study, we observed these changes following 5
days and 14 days of UUO in both wild-type and AT2 null mutant
mice. However, it was remarkably apparent that Agtr2 2/Y mice
have more severe interstitial fibrosis than Agtr2 1/Y mice. Point-
counting on the Masson trichrome-stained sections indeed re-
vealed that the obstructed kidneys of Agtr2 2/Y mice had more
collagen deposition in the cortical interstitium than Agtr2 1/Y
mice at both time-points. Northern blot analysis for mRNA
expression of a1(I) collagen, which is a main component of the
increased interstitial matrix during fibrosis, showed a greater
collagen synthesis in 5-day obstructed kidneys of Agtr2 2/Y when
compared with that of wild-type.
Obstruction causes a persistent increase in the numbers of
monocytes/macrophages and fibroblast-like cells [16, 17]. It is
believed that the interstitial matrix is composed of collagens and
other matrix proteins, such as fibronectin and various proteogly-
cans [36]. Collagens responsible for interstitial fibrosis are synthe-
sized and released by fibroblasts and injured tubules, the latter
producing collagens of basement membrane type in normal
condition [37]. Injured tubules can also contribute to interstitial
fibrosis, directly or indirectly, by releasing some cytokines and
chemokines. These cytokines promote the recruitment of mono-
cytes/macrophages and lymphocytes, the synthesis and release of
collagens from fibroblasts, while inhibiting the degradation of
interstitial collagen [38–42]. Infiltrating macrophages and lym-
phocytes can also release cytokines and chemokines, which can
induce collagen production from fibroblasts as well as cause
further injury of the tubules [43, 44].
F4/80 antigen has been proven to be a specific marker for
macrophages in many tissues [23]. Our immunohistochemical
study with F4/80 antibody showed significantly increased accumu-
lation of macrophages in obstructed kidneys. The number of
macrophages appearing in kidneys from Agtr2 1/Y and Agtr2 2/Y
mice was comparable following 5 days or 14 days of UUO. Thus,
a quantitative difference in infiltrating macrophages does not
underlie the observed difference in the extent of interstitial
fibrosis between the two genotypes. This result is consistent with
a report in which no difference in macrophage infiltration was
found with or without using AT2 antagonist PD123319 on UUO
rats [45].
Vimentin is a mesenchymal cell marker, expressed in endothe-
lia, vessel walls, and fibroblasts [46]. In our study, glomeruli and
vasculature were excluded from evaluation; therefore, the ob-
served vimentin-positive cells were regarded as fibroblasts. In
Fig. 7. Quantitative analysis of fibroblast population in the cortex of
5-day and 14-day obstructed kidneys of Agtr2 1/Y and Agtr2 2/Y mice.
Vimentin-positive cell populations in obstructed kidneys of Agtr2 2/Y (M)
mice were greater than in Agtr2 1/Y mice (f). Increase of vimentin-
positive cells were detected in obstructed kidneys after 14-day unilateral
ureteral obstruction (UUO) compared with 5-day UUO. Values are
expressed as mean 6 SEM. *P , 0.05, **P , 0.01.
Fig. 8. Quantitative analysis of proliferating cell (PCNA-positive cell) in
the cortical tubulointerstitium of 5-day and 14-day obstructed (f) and
contralateral (o) kidneys of Agtr2 1/Y and Agtr2 2/Y mice. There were
more tubulointerstitial proliferating cells in obstructed kidneys than
contralateral kidneys of both genotypes at both time-points. Among the
obstructed kidneys, there was no significant difference in the number of
PCNA-positive cells between Agtr2 1/Y and Agtr2 2/Y mice. Values are
expressed as mean 6 SEM. *P , 0.05.
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obstructed kidneys, intensive vimentin staining was found in
interstitial cells. The pattern of vimentin positivity duplicates that
of Masson trichrome stain-positivity. Thus, 14-day UUO had
more vimentin-positive cells in cortical interstitium than 5-day
UUO, and UUO from Agtr2 2/Y animal had more vimentin-
positive cells than UUO from the Agtr2 1/Y. These results of
vimentin positivity were essentially duplicated by aSMA positivity,
which was taken to identify myofibroblasts. Most notably, the
latter carry a high synthetic capacity for fibrillar collagens and
various cytokines [47]. The study, therefore, revealed that UUO in
Agtr2 2/Y mice causes a greater increase in collagen-producing
cells, that is, fibroblasts, than the same insult in wild-type mice.
Our experiments with PCNA antibody showed that proliferat-
ing cells are located mainly in tubules with a few in the interstitial
space after 5 days and 14 days of UUO. There was no detectable
difference in the number or in the pattern of distribution of
proliferating cells between Agtr2 2/Y and Agtr2 1/Y mice. Thus,
our results do not support the idea that AT2 has a significant
impact on cell proliferation during UUO. However, since PCNA
is expressed during the S-G1 stage of the cell cycle, and is thought
not only to be a cell proliferation marker but also to be a marker
of DNA repair [34, 48, 49], the result of our experiments should
be considered circumspectly.
AT2 has been linked to apoptosis [4, 5]. Previously, apoptotic
activity was found in the interstitium of kidneys that had been
obstructed for 2 to 4 weeks [33, 35]. Moreover, the gene expres-
sion of p53 often involved in cell apoptosis was found to be
down-regulated in 5-day UUO rats treated with PD123319 [45].
Our current study showed that tubulointerstitial apoptosis deter-
mined by ISEL method is present after five days and 14 days
following UUO, predominantly in tubular epithelial cells but also
including a few capillary endothelial cells and interstitial cells. In
the renal cortex of 14-day UUO from Agtr2 2/Y mice, the number
of ISEL-positive cells was significantly smaller than that of Agtr2
1/Y animals, while in 5-day UUO no difference between two
genotypes could be detected. Similar results have been reported
by Morrissey, Duan and Klahr [45] in their studies of rats given a
pharmacological AT2 inhibitor. However, because of the relative
rarity of ISEL positivity present in tubulointerstitial cells, it
remains uncertain whether decreased apoptotic activity also char-
acterizes the interstitial fibroblasts of Agtr2 2/Y during UUO and
underlies their abnormal abundance.
In summary, we found that Agtr2 2/Y are characterized by a
more extensive and severe response to a renal injury causing
interstitial fibrosis compared with animals with intact AT2. This
exaggerated damage was associated with more fibroblasts, which
are a potential source of collagens. We also found less apoptosis
in these kidneys of AT2 null mutants, which may contribute to
these more profound interstitial changes.
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